Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 18,396 |
|
|||||
| News | - | ||||||
| Day High | 10.18 | Low High |
|||||
| Day Low | 9.94 | ||||||
| Company Name | Etf Ticker Symbol | Market | Type |
|---|---|---|---|
| Global X Genomics and Biotechnology | GNOM | NASDAQ | Exchange Traded Fund |
| Price Change | Change Percent | Etf Price | Last Traded
|
|
|---|---|---|---|---|
| 0.205 | 2.07% | 10.095 | 11:55:09 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.95 | 9.94 | 10.18 | 9.89 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 149 | 18,396 | 10.13 | 186,387 | - | 8.63 - 13.33 |
| Last Trade Time | Type | Quantity | Etf Price | Currency |
|---|---|---|---|---|
| 11:55:04 | 100 | 10.095 | USD |
Global X Genomics and Biotechnology Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 90.83M | 8.94M | - | 300k | -58.84M | -6.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Global X Genomics and Bi...
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
GNOM Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.0208 | 10.18 | 9.575 | 9.85 | 52,547 | 0.0742 | 0.74% |
| 1 Month | 11.34 | 11.48 | 9.575 | 10.63 | 51,798 | -1.25 | -10.98% |
| 3 Months | 11.16 | 12.5338 | 9.575 | 11.41 | 76,811 | -1.07 | -9.54% |
| 6 Months | 9.14 | 12.5338 | 8.63 | 10.02 | 149,840 | 0.955 | 10.45% |
| 1 Year | 12.54 | 13.33 | 8.63 | 10.52 | 138,654 | -2.45 | -19.50% |
| 3 Years | 22.56 | 25.68 | 8.63 | 13.96 | 123,627 | -12.47 | -55.25% |
| 5 Years | 14.18 | 28.45 | 8.63 | 15.53 | 90,837 | -4.09 | -28.81% |
| The investment seeks to provide investment results that correspond generally to the price and yield performance before fees and expenses of the Solactive Genomics Index underlying index. The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchangelisted companies that are positioned to benefit from further advances in the field of genomic science and biotechnology as well as applications thereof collectively Genomics Biotechnology Companies as defined by Solactive AG the provider of the underlying index. The fund is nondiversified. The fund invests at least 80% of its total assets in the securities of the underlying index. |
